Current and future therapeutic approaches for the treatment of small cell lung cancer

被引：36
|
作者：
Rossi, Antonio [1 ]
Tay, Rebecca [2 ]
Chiramel, Jaseela [2 ]
Prelaj, Arsela [2 ,3 ]
Califano, Raffaele [2 ,4 ,5 ]
机构：
[1] Sci Inst Res & Hlth Care IRCCS Casa Sollievo dell, Div Med Oncol, San Giovanni Rotondo, Italy
[2] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[3] Sapienza Univ Rome, Dept Radiol Pathol & Oncol Sci, Rome, Italy
[4] Manchester Univ NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[5] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2018年 / 18卷 / 05期
关键词：
Durvalumab; immunotherapy; ipilimumab; nivolumab; pembrolizumab; rovalpituzumab tesirine; SCLC; second-line; targeted therapy; tremelimumab; PHASE-III TRIAL; PROPHYLACTIC CRANIAL IRRADIATION; PACLITAXEL PLUS BEVACIZUMAB; PLACEBO-CONTROLLED TRIAL; ANTIBODY-DRUG CONJUGATE; DOUBLE-BLIND; OPEN-LABEL; 2ND-LINE TREATMENT; THORACIC RADIOTHERAPY; 1ST-LINE TREATMENT;
D O I：
10.1080/14737140.2018.1453361
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Introduction: Small-cell lung cancer (SCLC) is a very aggressive disease characterized by a high response rate to first-line chemotherapy, but most patients relapse within 1year with disappointing results to second-line treatments. Chemotherapy has reached a plateau of effectiveness and new therapeutic strategies are needed to change the natural history of SCLC.Areas covered: This review will focus on the current results and the future development of the therapeutic approaches for the treatment of SCLC.Expert commentary: Immunotherapy is becoming a new frontier for the management of SCLC with preliminary interesting results. To date, no targeted drugs have been approved for clinical practice but several novel agents are in an advanced stage of clinical development in SCLC.
引用
收藏
页码：473 / 486
页数：14
相关论文
共 50 条
  • [1] Breaking the Impasse Advances in Treatment of Small Cell Lung Cancer
    Saltos, Andreas
    Antonia, Scott
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 269 - +
  • [2] Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer
    Rijavec, Erika
    Genova, Carlo
    Biello, Federica
    Rossi, Giovanni
    Indini, Alice
    Grossi, Francesco
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (11) : 1427 - 1435
  • [3] Novel immunotherapy in the treatment of advanced non-small cell lung cancer
    Santabarbara, G.
    Maione, P.
    Rossi, A.
    Palazzolo, G.
    Gridelli, C.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (12) : 1571 - 1581
  • [4] Immune checkpoint blockade in small cell lung cancer
    Tay, Rebecca Y.
    Heigener, David
    Reck, Martin
    Califano, Raffaele
    LUNG CANCER, 2019, 137 : 31 - 37
  • [5] Immunotherapy in Small Cell Lung Cancer
    Esposito, Giovanna
    Palumbo, Giuliano
    Carillio, Guido
    Manzo, Anna
    Montanino, Agnese
    Sforza, Vincenzo
    Costanzo, Raffaele
    Sandomenico, Claudia
    La Manna, Carmine
    Martucci, Nicola
    La Rocca, Antonello
    De Luca, Giuseppe
    Piccirillo, Maria Carmela
    De Cecio, Rossella
    Botti, Gerardo
    Totaro, Giuseppe
    Muto, Paolo
    Picone, Carmine
    Normanno, Nicola
    Morabito, Alessandro
    CANCERS, 2020, 12 (09) : 1 - 17
  • [6] Current and future perspectives in extensive-stage small-cell lung cancer
    Lim, Jeong Uk
    Ryu, Woo Kyung
    Park, Nuri
    Choi, Juwhan
    Lee, Eunyoung
    Lee, Sang-Yun
    Lim, Jun Hyeok
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
  • [7] Immunotherapy in Small Cell Lung Cancer Treatment: a Promising Headway for Future Perspective
    Walia, Harleen Kaur
    Sharma, Parul
    Singh, Navneet
    Sharma, Siddharth
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (02) : 268 - 294
  • [8] Treatment of small cell lung cancer
    Morabito, Alessandro
    Carillio, Guido
    Daniele, Gennaro
    Piccirillo, Maria Carmela
    Montanino, Agnese
    Costanzo, Raffaele
    Sandomenico, Claudia
    Giordano, Pasqualina
    Normanno, Nicola
    Perrone, Francesco
    Rocco, Gaetano
    Di Maio, Massimo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 91 (03) : 257 - 270
  • [9] What's new in small cell lung cancer - extensive disease? An overview on advances of systemic treatment in 2016
    Seeber, Andreas
    Leitner, Christoph
    Philipp-Abbrederis, Kathrin
    Spizzo, Gilbert
    Kocher, Florian
    FUTURE ONCOLOGY, 2017, 13 (16) : 1427 - 1435
  • [10] PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approaches
    Barayan, Ranya
    Ran, Xiaozhuo
    Lok, Benjamin H.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 6240 - 6252
12345